SphK2/S1P Regulates Regorafenib Resistance of HCC Cells by Inducing the Activation of Nuclear Factor κB and Signal Transducer and Activator of Transcription 3. This evidence concerns the gene MBTPS1 and hepatocellular carcinoma.